Ranbaxy launches authorised omeprazole generic in US
This article was originally published in Scrip
Ranbaxy Laboratories' US subsidiary has launched an authorised generic of omeprazole 40mg capsules under an agreement withAstraZeneca Pharmaceuticals. Omeprazole 40mg, a generic version of AstraZeneca's Prilosec, is used to treat acid-related disease, including gastric ulcer and Zollinger-Ellison syndrome. Prilosec 40mg reported sales of $204.2 million in the US for the 12 months to March 2008. Ranbaxy Laboratories, which is in the process of being acquired by Daiichi Sankyo launched its first authorised generic, verapamil SR, under an agreement with FSC Laboratories last year. Verapamil SR is a generic version of FSC Laboratories' calcium ion antagonist, Isoptin SR.